Atlas Trials

Immune Durability After VSV-EBOV Vaccination

Clinical trial NCT02933931 · COMPLETED

Trial details

NCT number
NCT02933931
Sponsor
University Hospital, Geneva
Status
COMPLETED
Study type
OBSERVATIONAL
Immune ResponseVaccinationDurability
Start date
2016-11-01
Primary completion
2020-01-01
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.